CASE REPORT: Post-Liver Transplant Crohn's Disease: Graft Tolerance but Not Self-Tolerance?

[1]  M. Zeitz,et al.  Development of ulcerative colitis under the immunosuppressive effect of cyclosporine , 1992, The clinical investigator.

[2]  S. James,et al.  The immunologic basis of inflammatory bowel disease , 1986, Journal of Clinical Immunology.

[3]  A. Pisani,et al.  Oral tacrolimus long‐term therapy in patients with Crohn’s disease and steroid resistance , 2001, Alimentary pharmacology & therapeutics.

[4]  J. Benhamou.  [Primary sclerosing cholangitis]. , 2000, La Revue du praticien.

[5]  S. Targan,et al.  Cytokine-based therapies in inflammatory bowel disease. , 1999, Current opinion in gastroenterology.

[6]  M. Neurath,et al.  Role of NF-κB in immune and inflammatory responses in the gut , 1998 .

[7]  A. Burroughs,et al.  Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis , 1998, Gut.

[8]  K. Fellermann,et al.  Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506) , 1998, American Journal of Gastroenterology.

[9]  S. Bickston,et al.  Treatment of Crohn's disease at the turn of the century. , 1998, The New England journal of medicine.

[10]  G. Lichtenstein.  Medical therapies for inflammatory bowel disease , 1993, Hospital Practice.

[11]  C. Liv.  CLINICAL COURSE AND MANAGEMENT OF INFLAMMATORY BOWEL DISEASE AFTER LIVER TRANSPLANTATION , 1998 .

[12]  A. Tursi,et al.  Onset of ulcerative colitis during immunosuppressive therapy for liver transplantation. , 1997, American Journal of Gastroenterology.

[13]  S. Targan,et al.  A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease , 1997 .

[14]  W. Sandborn.  Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. , 1997, The American journal of gastroenterology.

[15]  Randall G. Lee,et al.  A case series of transplant recipients who despite immunosuppression developed inflammatory bowel disease. , 1997, The American journal of gastroenterology.

[16]  B. Volk,et al.  Phenotypic and immunoregulatory analysis of intestinal T‐cells in patients with inflammatory bowel disease: evaluation of an in vitro model , 1995, European journal of clinical investigation.

[17]  K. Batts,et al.  Reliability and predictive value of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database nomenclature and grading system for cellular rejection of liver allografts. , 1995, Hepatology.

[18]  O. Nielsen,et al.  Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. , 1994, Digestive diseases.

[19]  A. Laupacis,et al.  Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators. , 1994, The New England journal of medicine.

[20]  R. Sartor.  Cyclosporine therapy for inflammatory bowel disease. , 1994, The New England journal of medicine.

[21]  T. Macdonald,et al.  Aetiology and pathogenesis of chronic inflammatory bowel disease. , 1994, Bailliere's clinical gastroenterology.

[22]  N. LaRusso,et al.  Primary sclerosing cholangitis. , 1984, Journal of gastroenterology.

[23]  R. Wiesner,et al.  Current concepts in primary sclerosing cholangitis. , 1984, Mayo Clinic proceedings.

[24]  G. Klintmalm,et al.  Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. , 1993, Transplantation proceedings.

[25]  W. Sandborn,et al.  Cyclosporine treatment of inflammatory bowel disease. , 1992, Mayo Clinic proceedings.

[26]  R. Busuttil,et al.  The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. , 1992, Annals of surgery.

[27]  D. Jewell,et al.  Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. , 1991, Gut.

[28]  S N Rasmussen,et al.  A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. , 1989, The New England journal of medicine.

[29]  M. Cappell,et al.  Terminal ileitis associated with cytomegalovirus and the acquired immune deficiency syndrome. , 1989, The American journal of gastroenterology.

[30]  J. Scholes,et al.  Evaluation of diagnostic criteria for mucosal cytomegalic inclusion disease in the acquired immune deficiency syndrome. , 1987, The American journal of gastroenterology.

[31]  G. Eliopoulos,et al.  Widespread cytomegalovirus gastroenterocolitis in a patient with acquired immunodeficiency syndrome. , 1983, Gastroenterology.